Sionna Therapeutics, Inc. Common Stock (SION) — Financial Flexibility Index
Sionna Therapeutics, Inc. Common Stock (SION) has a Financial Flexibility Index of -0.86x as of December 2025. Free cash flow of $-16.42 Million (operating CF $-16.63 Million minus capex $204.00K) represents -1% of total liabilities ($19.12 Million). Also explore SION shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sionna Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Sionna Therapeutics, Inc. Common Stock across 4 annual periods. Check asset allocation strategy of Sionna Therapeutics, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sionna Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Sionna Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Sionna Therapeutics, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.45x | $-65.92 Million | $-66.30 Million | $19.12 Million | ▼ -2183.6% |
| 2024 | -0.15x | $-52.76 Million | $-52.79 Million | $349.46 Million | ▲ +40.9% |
| 2023 | -0.26x | $-42.58 Million | $-43.70 Million | $166.83 Million | ▼ -17.4% |
| 2022 | -0.22x | $-34.19 Million | $-36.07 Million | $157.29 Million | — |